Roche at ESMO Asia 2022

Unlocking new possibilities for better cancer care.

To see where oncology care is headed, visit us at ESMO Asia Congress 2022, 2 to 4 December (booth #C101). We’ll share how our navify Oncology portfolio supports comprehensive, personalized cancer care, providing holistic data-driven insights for improved clinical decision-making and operational efficiency.

Shaping the future of oncology care. It’s personal.

At Roche, we aim to create a more connected, secure and efficient healthcare system, where digital solutions clarify navigation throughout the oncology care continuum, unlocking new possibilities for better cancer care.

Our navify Oncology portfolio is designed to re-define patient management in oncology. With its intuitive and intelligent software, navify Oncology portfolio streamlines clinical workflows and improves collaboration across care teams, providing quick access to relevant, actionable data and up-to-date clinical insights to aid clinicians in more effective care decisions and timely access to care—all in a secure, compliant environment. We are aiding in transforming the way cancer care is delivered.

Visit us at ESMO Asia Congress 2022, 2-4 December (booth #C101), at Suntec Singapore Convention & Exhibition Centre, to discover how we are empowering care that is efficient, timely, and personalised.

End-to-end solutions across the cancer care continuum.

Visit our Booth #3943 and learn more about our digital portfolio.

navify Tumor Board – Improving multidisciplinary tumor board preparation and discussion, enabling providers to securely access, review and share relevant health and medical data, resulting in more timely and personalised cancer care. Learn more

Research Tools

navify Mutation Profiler* – is a Next Generation Sequencing (NGS) reporting solution that can help labs & researchers confidently, clearly and efficiently interpret the significance of mutations. navify Mutation Profiler increases lab efficiency and enables scalability by helping reduce curation time and by automating report generation. Learn more

*navify Mutation Profiler is Research Use Only in the US. Not for use in diagnostic procedures.

We hope to see you in Singapore!

Register today to meet our team in person,

find us at booth number C101.

Can’t attend, sign up to stay connected.